JP2013544809A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544809A5 JP2013544809A5 JP2013537197A JP2013537197A JP2013544809A5 JP 2013544809 A5 JP2013544809 A5 JP 2013544809A5 JP 2013537197 A JP2013537197 A JP 2013537197A JP 2013537197 A JP2013537197 A JP 2013537197A JP 2013544809 A5 JP2013544809 A5 JP 2013544809A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- over
- period
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 28
- 239000002202 Polyethylene glycol Substances 0.000 claims 11
- 229920001223 polyethylene glycol Polymers 0.000 claims 11
- 206010009944 Colon cancer Diseases 0.000 claims 7
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 7
- 239000004698 Polyethylene Substances 0.000 claims 6
- 241000282412 Homo Species 0.000 claims 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 3
- 229930195725 Mannitol Natural products 0.000 claims 3
- 239000000594 mannitol Substances 0.000 claims 3
- 235000010355 mannitol Nutrition 0.000 claims 3
- 229960001855 mannitol Drugs 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 2
- 239000008101 lactose Substances 0.000 claims 2
- 239000000314 lubricant Substances 0.000 claims 2
- 206010010774 Constipation Diseases 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 208000037062 Polyps Diseases 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 239000007894 caplet Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 235000010980 cellulose Nutrition 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 229940096516 dextrates Drugs 0.000 claims 1
- 239000003792 electrolyte Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 230000003862 health status Effects 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000845 maltitol Substances 0.000 claims 1
- 235000010449 maltitol Nutrition 0.000 claims 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims 1
- 229940035436 maltitol Drugs 0.000 claims 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 1
- 208000014081 polyp of colon Diseases 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000000750 progressive effect Effects 0.000 claims 1
- 239000008247 solid mixture Substances 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- -1 troche Substances 0.000 claims 1
- 239000000811 xylitol Substances 0.000 claims 1
- 235000010447 xylitol Nutrition 0.000 claims 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 1
- 229960002675 xylitol Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1018650.0A GB201018650D0 (en) | 2010-11-04 | 2010-11-04 | Methods and compositions |
| GB1018650.0 | 2010-11-04 | ||
| US41212810P | 2010-11-10 | 2010-11-10 | |
| US61/412,128 | 2010-11-10 | ||
| PCT/GB2011/001561 WO2012059725A1 (en) | 2010-11-04 | 2011-11-04 | Peg or peg block copolymers for treating colorectal cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013544809A JP2013544809A (ja) | 2013-12-19 |
| JP2013544809A5 true JP2013544809A5 (enExample) | 2014-11-27 |
| JP5917537B2 JP5917537B2 (ja) | 2016-05-18 |
Family
ID=43414365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537197A Expired - Fee Related JP5917537B2 (ja) | 2010-11-04 | 2011-11-04 | 結腸直腸ガンを治療するためのｐｅｇ又はｐｅｇブロックコポリマー |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20130216493A1 (enExample) |
| EP (1) | EP2635289B1 (enExample) |
| JP (1) | JP5917537B2 (enExample) |
| KR (1) | KR20130109171A (enExample) |
| CN (1) | CN103313719A (enExample) |
| AR (1) | AR083770A1 (enExample) |
| AU (1) | AU2011324996B2 (enExample) |
| BE (1) | BE1019494A3 (enExample) |
| BR (1) | BR112013011012A2 (enExample) |
| CA (1) | CA2816839A1 (enExample) |
| EA (1) | EA201300540A1 (enExample) |
| ES (1) | ES2401269B1 (enExample) |
| GB (1) | GB201018650D0 (enExample) |
| MX (1) | MX349690B (enExample) |
| MY (1) | MY163067A (enExample) |
| NL (1) | NL2007715C2 (enExample) |
| NZ (1) | NZ611145A (enExample) |
| SG (1) | SG189533A1 (enExample) |
| TW (1) | TWI606832B (enExample) |
| UA (1) | UA107998C2 (enExample) |
| WO (1) | WO2012059725A1 (enExample) |
| ZA (1) | ZA201304052B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI535461B (zh) | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法 |
| NZ743984A (en) | 2012-09-11 | 2019-10-25 | Norgine Bv | Compositions comprising polyethylene glycol, alkali metal or alkaline earth metal sulphates and electrolytes for use as colon cleansing compositions |
| AR093153A1 (es) * | 2012-10-26 | 2015-05-20 | Northshore Univ Healthsystem | Composiciones que comprenden polietilenglicol para la terapia del carcinoma de celulas escamosas de cabeza y cuello |
| CN103083733A (zh) * | 2013-02-19 | 2013-05-08 | 华熙福瑞达生物医药有限公司 | 一种医用体腔器械导入水性润滑剂 |
| CN113507933B (zh) * | 2019-03-05 | 2024-05-10 | 陶氏环球技术有限责任公司 | 诱导胱天蛋白酶活性 |
| CN113473996B (zh) | 2019-03-05 | 2024-05-24 | 陶氏环球技术有限责任公司 | 诱导胱天蛋白酶活性 |
| JP7487220B2 (ja) * | 2019-03-05 | 2024-05-20 | ダウ グローバル テクノロジーズ エルエルシー | カスパーゼ活性を誘導するためのポリエチレングリコール誘導体 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2784897B1 (fr) | 1998-10-27 | 2002-11-29 | Agronomique Inst Nat Rech | Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux |
| WO2006122104A1 (en) * | 2005-05-06 | 2006-11-16 | Salix Pharmaceuticals, Inc. | Polyethylene glycol colonic purgative composition |
| US8457025B2 (en) * | 2009-08-28 | 2013-06-04 | Telefonaktiebolaget L M Ericsson (Publ) | Method and network node for selecting a network prefix to be advertised in a communication network |
-
2010
- 2010-11-04 GB GBGB1018650.0A patent/GB201018650D0/en not_active Ceased
-
2011
- 2011-04-11 UA UAA201307040A patent/UA107998C2/uk unknown
- 2011-11-04 AU AU2011324996A patent/AU2011324996B2/en not_active Ceased
- 2011-11-04 KR KR1020137013977A patent/KR20130109171A/ko not_active Ceased
- 2011-11-04 BR BR112013011012A patent/BR112013011012A2/pt not_active IP Right Cessation
- 2011-11-04 MX MX2013004963A patent/MX349690B/es active IP Right Grant
- 2011-11-04 MY MYPI2013001602A patent/MY163067A/en unknown
- 2011-11-04 EP EP11785050.3A patent/EP2635289B1/en active Active
- 2011-11-04 TW TW100140231A patent/TWI606832B/zh not_active IP Right Cessation
- 2011-11-04 NZ NZ611145A patent/NZ611145A/en not_active IP Right Cessation
- 2011-11-04 EA EA201300540A patent/EA201300540A1/ru unknown
- 2011-11-04 CA CA2816839A patent/CA2816839A1/en not_active Abandoned
- 2011-11-04 SG SG2013032008A patent/SG189533A1/en unknown
- 2011-11-04 US US13/883,262 patent/US20130216493A1/en not_active Abandoned
- 2011-11-04 AR ARP110104129A patent/AR083770A1/es unknown
- 2011-11-04 ES ES201131772A patent/ES2401269B1/es not_active Expired - Fee Related
- 2011-11-04 WO PCT/GB2011/001561 patent/WO2012059725A1/en not_active Ceased
- 2011-11-04 NL NL2007715A patent/NL2007715C2/en not_active IP Right Cessation
- 2011-11-04 CN CN201180064013XA patent/CN103313719A/zh active Pending
- 2011-11-04 BE BE2011/0645A patent/BE1019494A3/fr not_active IP Right Cessation
- 2011-11-04 JP JP2013537197A patent/JP5917537B2/ja not_active Expired - Fee Related
-
2013
- 2013-06-03 ZA ZA2013/04052A patent/ZA201304052B/en unknown
-
2016
- 2016-04-21 US US15/134,410 patent/US20160228467A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013544809A5 (enExample) | ||
| Ali et al. | Dental erosion caused by silent gastroesophageal reflux disease | |
| Kurin et al. | Sorting out the relationship between gastroesophageal reflux disease and sleep | |
| CN107510846A (zh) | 植物大麻素大麻二酚（cbd）与标准抗癫痫药物（saed）组合在治疗癫痫中的用途 | |
| JP2012533565A5 (enExample) | ||
| TW200843802A (en) | Compositions for improving gastrointestinal nutrient and drug absorption | |
| CN108367041A (zh) | 用于不希望的或异常的肌肉收缩的方法和组合物 | |
| JP2014500246A5 (enExample) | ||
| EP2635289B1 (en) | Peg or peg block copolymers for treating colorectal cancer | |
| JP2018076348A (ja) | 経口薬剤用補助手段としての組成物とその製造方法 | |
| US20180098940A1 (en) | Pediatric formulation | |
| RU2725743C2 (ru) | Продукт на основе хелата бис-глицината железа и альгиновой кислоты и/или ее водорастворимых солей, его составы и его фармацевтические применения | |
| JP6779871B2 (ja) | がん患者のための口腔ケア用組成物 | |
| Contini et al. | Features and management of esophageal corrosive lesions in children in Sierra Leone: lessons learned from 175 consecutive patients | |
| AU2016277587B2 (en) | Buffered upper GI absorption promoter | |
| JP6549428B2 (ja) | 経口組成物 | |
| JP2007169247A (ja) | ショウガ含有経口組成物 | |
| US20210177805A1 (en) | Use of gaboxadol in the treatment of gastrointestinal tract disorders and asthma | |
| Zis et al. | Phenomenology of levodopa-induced dyskinesia | |
| JP2017513866A5 (enExample) | ||
| JP6762007B2 (ja) | 変形性関節症予防用組成物、変形性関節症予防用食品組成物、変形性関節症予防用食品添加物及び変形性関節症予防用医薬 | |
| JP2003095981A (ja) | 医薬組成物 | |
| Metz et al. | S1074 Tak-390MR, a Proton Pump Inhibitor with a Novel Dual Delayed Release Formulation, Maintains Healing and Controls Heartburn in GERD Patients with Healed Erosive Esophagitis | |
| JP5626698B1 (ja) | カルシウム低吸収型経口リン吸着剤 | |
| CN111246753A (zh) | 用于钙补充的组合物 |